News & Articles

Gene therapy is marking new frontiers with the recent FDA approvals of innovative treatments for sickle cell disease (SCD). Casgevy...

How VLPs are unlocking the next generation of antibody therapeutics for challenging transmembrane proteins Transmembrane proteins play crucial roles in...

For years, recombinant major histocompatibility complexes (MHCs) have been expressed in bacterial systems with in vitro refolding. While this preserves...

What are virus-like particles (VLPs)? Virus-like particles (VLPs) are nanoparticle structures (50-300nm diameter) that mimic the organization and conformation of...

Introducing Neoantigen-Based Immunotherapy Neoantigen-based immunotherapy is revolutionizing cancer treatment by focusing on neoantigens—unique proteins formed by mutations in cancer cells....

KACTUS, the strategic partner of Base Therapeutics, is the exclusive supplier of GMP-grade AccuBase™, the world’s first “off-the-shelf” cytosine base...

In a groundbreaking development for the biotech industry, KACTUS's GMP-grade Cas9 has critically helped Yizun Bio secure IND clearance for a universal...

Exciting news of mRNA vaccine research against monkeypox has been coming out since the beginning of 2024: February 15, the...

Thymic Stromal Lymphopoietin (TSLP), is a pleiotropic cytokine of the IL-2 family, closely related to IL-7, playing a significant role...

Casgevy, the world's first drug based on CRISPR/Cas9 gene-editing technology, was approved for market release at the end of 2023,...

Function and Signaling Pathway of Integrin αvβ6 Integrin αvβ6 (hereinafter referred to as αvβ6) belongs to the integrin family of...

On October 7, 2024, Scholar Rock announced that the Phase III clinical trial (SAPPHIRE) of Apitegromab (SRK-015) met its primary...